A consignment of around 90 tonnes of nine different Made in India Active Pharmaceutical Ingredients (APIs) left Mundra port for the Republic of Cuba on June 2, 2024. These APIs are critical for producing essential antibiotics that are needed for the treatment of chronic communicable diseases.
The APIs sent by India will be utilized by Cuban drug manufacturers to produce antibiotics in various forms such as tablets, capsules, syrups, and injections. These forms are crucial for effective treatment and management of chronic diseases that have a significant impact on public health in Cuba. This initiative is part of India’s broader effort to support global health and to provide assistance to countries in need.
India’s role as a major supplier of pharmaceuticals is well recognized globally and is often referred to as the “Pharmacy of the World” due to its vast production and export of generic medicines. The current consignment to Cuba further solidifies this status and showcases India’s capability to provide high-quality pharmaceuticals to the international community.
Bilateral Relations
The relationship between India and Cuba is historic and deeply rooted in mutual respect and cooperation. Over the years, the two countries have maintained strong diplomatic ties and have collaborated on various fronts including healthcare, education, and technology. The humanitarian aid provided by India underscores its commitment to maintaining and strengthening these ties.
This gesture of goodwill is not just about providing medicines; it is about reaffirming India’s dedication to global health and its readiness to support its friends in times of need. The assistance to Cuba is a testament to India’s proactive role in addressing global health challenges and its unwavering support for countries facing medical crises.
The shipment of 90 tonnes of APIs to Cuba is a significant act of humanitarian assistance that highlights the country’s role as a global healthcare provider and its enduring friendship with Cuba.
